Intranasal nanoparticle targeting neutrophil ORAI1 mitigates pancreatitis- and sepsis-associated acute lung injury
Journal of Controlled Release · 2026
DOI: 10.1016/j.jconrel.2026.115253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2026. Verfasst von Zihan Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 10…. Hauptthemen laut MEDLINE: Acute Lung Injury, Nanoparticles, Neutrophils, ORAI1 Protein. Die Arbeit nennt 72 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shandong Province Natural Science Foundation, National Key Research and Development Program of China.
Themen: Sepsis
Abstract (Originalsprache)
Acute lung injury arising from acute pancreatitis or sepsis remains a major clinical challenge and lacks specific therapeutic strategies. Neutrophil activation and infiltration, tightly governed by intracellular Ca2+ signaling via ORAI1-based Ca2+ release-activated Ca2+ (CRAC) channels, play central roles in the pathogenesis of acute lung injury. Here, we engineered a neutrophil-targeted lipid nanoparticle (neutLNP) encapsulating the selective CRAC channel inhibitor CM4620 (Anti-Ly6G@CM4620-LNP) for intranasal delivery. The neutLNP efficiently suppressed neutrophil chemotaxis and reactive oxygen species production, and significantly attenuated lung injury in both pancreatitis- and sepsis-associated lung injury models. Compared with intranasally administered free CM4620, neutLNP produced greater reductions in selected histological and inflammatory endpoints. Pulmonary imaging and flow cytometry demonstrated distribution within the inflamed lung parenchyma and preferential association with pulmonary neutrophils, whereas pharmacokinetic analysis showed markedly lower plasma CM4620 exposure after intranasal than after intraperitoneal administration. Mechanistically, integrated transcriptomic and single-cell proteomic profiling of pulmonary neutrophils from neutrophil-specific Orai1-deficient mice identified CD166 as a downstream mediator of ORAI1 signaling. Further analyses showed that ORAI1 signaling transcriptionally promotes CD166 expression, at least in part through NFATc2. Together, these findings support intranasal neutLNP delivery as a locally directed strategy that enhances lung protection relative to intranasal free CM4620 while limiting systemic exposure compared with intraperitoneal delivery, and establish CD166 as a functionally important downstream mediator of ORAI1-dependent neutrophil adhesion in acute inflammatory lung injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China; Center for Biomarker Discovery and Validation, National I…
- School of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences, Qingdao, Shandong 266071, China.
- Department of Biochemistry and Biophysics, School of Basic Medical Sciences, Peking University, Beijing 100191, China.
- Center for Biomarker Discovery and Validation, National Infrastructures for Translational Medicine (PUMCH), Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beij…
- State Key Laboratory of Complex, Severe, and Rare Diseases, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing 100730, China. Electronic address: catclw321…
- Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China. Electronic address: wudong@pumch.cn.
Förderung
- National Natural Science Foundation of China
- Shandong Province Natural Science Foundation
- National Key Research and Development Program of China
Zitieren
APA
Yang, Z., Meng, Q., Zhu, L., Qiu, B., Chen, Y., Lu, W., Zhang, X., Peng, K., Wong, C. C. L., Wu, D., & Wen, L. (2026). Intranasal nanoparticle targeting neutrophil ORAI1 mitigates pancreatitis- and sepsis-associated acute lung injury. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2026.115253
Vancouver
Yang Z, Meng Q, Zhu L, Qiu B, Chen Y, Lu W, et al. Intranasal nanoparticle targeting neutrophil ORAI1 mitigates pancreatitis- and sepsis-associated acute lung injury. Journal of Controlled Release. 2026. doi:10.1016/j.jconrel.2026.115253
BibTeX
@article{Yang2026,
author = {Yang, Zihan and Meng, Qingye and Zhu, Liu and Qiu, Bintao and Chen, Yonghao and Lu, Wanyi and Zhang, Xiuli and Peng, Kaixin and Wong, Catherine C L and Wu, Dong and Wen, Li},
title = {Intranasal nanoparticle targeting neutrophil ORAI1 mitigates pancreatitis- and sepsis-associated acute lung injury},
journal = {Journal of Controlled Release},
year = {2026},
doi = {10.1016/j.jconrel.2026.115253}
}
EUVIMED